WHITEHOUSE STATION, N.J.--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved GRASTEK® (Timothy Grass ...

(Reuters) - Merck & Co said the U.S. Food and Drug Administration on Monday approved its grass pollen allergy drug Grastek, becoming the second such immunotherapy treatment to be given the go-ahead in ...

ORALAIR® (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergenic Extract) is the Only Sublingual Allergy Immunotherapy Tablet with a Mix of Five Grass Allergen ...

The Willamette Valley set a new record for grass pollen counts on Tuesday morning, recording the highest level in 25 years of counting in Eugene. Read about the new record, what it means and how long ...

Oralair is indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen specific ...

(BPT) - Many people are surprised to learn that grass allergies are the most common seasonal allergy in the United States[i], [ii]and that most people are allergic to more than one type of grass.[iii] ...

The first pill that could replace allergy shots for some people has been approved by the Food and Drug Administration. Oralair, from the French company Stallergenes, only works against certain grass ...

LENOIR, N.C. – December 12, 2013 – GREER® Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the Allergenic Products Advisory ...

The Willamette Valley allergy season reached historic levels of misery Tuesday morning as grass pollen levels shattered previous records, according to Eugene's Oregon Allergy Associates counting ...

LONDON--(BUSINESS WIRE)--Regulatory News: Stallergenes Greer (Paris:STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, today announced that it has received ...